Owner Dana-Farber Cancer Institute, Inc.

Inventors Kufe, Donald, W.

Agent Davies Collison Cave

Pub. Number AU-B-2002246791

PCT Pub. Number WO2002/058450

Priority 60/308,307 27.07.01 US; 60/257,590 22.12.00 US

Filing date 26 December 2001

Wipo publication date 6 August 2002

Acceptance publication date 9 August 2007

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 31/7052 (2006.01)

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 38/00 (2006.01) Medicinal preparations containing peptides